Table 2.

Number (n) and percentage (%) of study variables amongst the study population by VIA status

		n (%)	n (%) VIA+	Crude OR VIA+	95% CI	P-value
FGS by PCR n = 237	Positive	14 (5.9)	4 (28.6)	4.06	1.15–14.38	0.044
	Negative	223 (94.1)	20 (9.0)	1
Visual FGS n = 216a	Positive	70 (29.5)	5 (7.1)	0.63	0.22–1.79	0.364
	Negative	146 (61.6)	16 (11.0)	1
CAA n = 236b	Positive	35 (14.8)	5 (14.3)		0.55–4.62	0.428
	Negative	201 (84.8)	19 (9.5)	1
Urine microscopy n = 237	Positive	15 (6.3)	3 (20.0)	2.39	0.62–9.23	0.237
	Negative	222 (93.7)	21 (9.5)	1
Age n = 237	18–22	64 (27.0)	5 (7.8)	1		0.112
	23–26	91 (38.4)	6 (6.6)	0.83	0.24–2.87
	27–31	82 (34.6)	13 (15.9)	2.22	0.74–6.68
HIV status n = 235c	Positive	56 (23.8)	8 (14.3)	1.7	0.68–4.23	0.265
	Negative	179 (76.2)	16 (8.9)	1
District n = 237	Community A	142 (59.9)	15 (10.6)	1		0.785
	Community B	95 (40.1)	9 (9.5)	0.89	0.37–2.12
Education n = 237	None or primary	74 (31.2)	11 (14.9)	1		0.113
	Secondary or higher	163 (68.8)	13 (8.0)	0.5	0.21–1.18
Employment n = 237	Unemployed	163 (68.8)	15 (9.2)	1		0.490
	Employed	74 (31.2)	9 (12.2)	1.37	0.57–3.29
Marital status n = 237	Currently single	116 (49.0)	14 (12.1)	1		0.331
	Currently married	121 (51.1)	10 (8.3)	0.66	0.28–1.55
Ever pregnant n = 237	Never	36 (15.2)	20 (10.0)	0.88	0.28–2.76	0.834
	Yes	201 (84.8)	4 (11.1)	1
Contraception n = 237	Yes	183 (77.2)	15 (8.2)	1		0.085
	No	54 (22.8)	9 (16.7)	2.24	0.91–5.50
Condoms n = 237	Yes	47 (19.8)	6 (12.8)	1.4	0.52–3.75	0.514
	No	190 (80.2)	18 (9.5)	1
Previous bilharzia diagnosis or treatment n = 237	Yes	29 (12.2)	3 (10.3)	1.09	0.30–3.94	0.630
	Unsure	10 (4.2)	2 (20.0)	2.36	0.46–12.00
	No	198 (83.5)	19 (9.6)	1

Abbreviations: CAA Circulating anodic antigen, CI Confidence interval, FGS female genital schistosomiasis, HIV Human immunodeficiency virus, OR odds ratio, PCR polymerase chain reaction, VIA Visual inspection with acetic acid

^a21 with uninterpretable images; ^bone urine vial arrived to LUMC empty; ^c2 results missing from HPTN-271 (PopART) database